Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Nora AI
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Pressmeddelande

Redeye: CTEK - More than meets the eye

CTEK

Redeye updates its estimates following CTEK’s Q4 report, which was largely impacted by General Motors generating one-time sales and write-downs simultaneously. CTEK generated solid underlying organic growth despite tough comps, but profitability was slightly below our estimates due to long-term investments putting a short-term dent in the margins. We are optimistic about 2025 for CTEK and consider the upcoming CMD a potential catalyst in increasing the stock market’s general understanding of the company’s ongoing business.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


CTEK - More than meets the eye

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.